News

2016.12.09News Release

The "Galderma Award" Transfers to Maruho

2016.11.04News Release

Maruho Launches Acne Vulgaris Treatment "Epiduo^® Gel" in Japan

2016.09.28News Release

Maruho and Astellas Enter License Agreement for the Development and Commercialization of a Topical Formulation of JAK Inhibitor peficitinib (ASP015K) for Treatment in the Skin Disease Area

2016.09.28News Release

Chugai and Maruho Announce License Agreement of Nemolizumab (CIM331), a Novel Biologic in the Skin Disease Area for the Japanese Market

2016.09.21News Release

Maruho enters a License Agreement with Dermira for Hyperhidrosis treatment agent DRM04

2016.09.16News Release

Maruho launches infantile hemangioma treatment"Hemangiol^® Syrup for Pediatric 0.375%" under a license from Pierre Fabre Laboratories

2016.07.20News Release

Maruho and Galderma Strengthen Strategic Alliance in Japan

2016.07.04News Release

Maruho receives manufacturing and marketing approval in Japan for infantile hemangioma treatment "Hemangiol^® Syrup for Pediatric 0.375%" under a license from Pierre Fabre Laboratories

2016.02.22News Release

Maruho Announces the Sixth Maruho Prize Winner, Award Ceremony and Lecture

2016.01.18News Release

Maruho and Galderma to Join Forces in a Strategic Alliance in Japan